Equillium Inc (EQ)
1.72
-0.09
(-4.97%)
USD |
NASDAQ |
Apr 26, 16:00
1.72
0.00 (0.00%)
After-Hours: 19:28
Equillium Enterprise Value: 22.95M for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 22.95M |
| April 24, 2024 | 22.24M |
| April 23, 2024 | 19.77M |
| April 22, 2024 | 17.30M |
| April 19, 2024 | 15.89M |
| April 18, 2024 | 20.12M |
| April 17, 2024 | 22.24M |
| April 16, 2024 | 24.36M |
| April 15, 2024 | 21.54M |
| April 12, 2024 | 24.36M |
| April 11, 2024 | 27.88M |
| April 10, 2024 | 24.71M |
| April 09, 2024 | 27.53M |
| April 08, 2024 | 26.82M |
| April 05, 2024 | 34.40M |
| April 04, 2024 | 37.40M |
| April 03, 2024 | 41.28M |
| April 02, 2024 | 35.99M |
| April 01, 2024 | 33.52M |
| March 28, 2024 | 40.57M |
| March 27, 2024 | 31.76M |
| March 26, 2024 | 31.76M |
| March 25, 2024 | 45.16M |
| March 22, 2024 | 58.55M |
| March 21, 2024 | 56.79M |
| Date | Value |
|---|---|
| March 20, 2024 | 60.67M |
| March 19, 2024 | 53.97M |
| March 18, 2024 | 52.21M |
| March 15, 2024 | 48.68M |
| March 14, 2024 | 49.03M |
| March 13, 2024 | 51.85M |
| March 12, 2024 | 48.33M |
| March 11, 2024 | 48.33M |
| March 08, 2024 | 53.26M |
| March 07, 2024 | 54.67M |
| March 06, 2024 | 38.81M |
| March 05, 2024 | 38.10M |
| March 04, 2024 | 37.75M |
| March 01, 2024 | 47.27M |
| February 29, 2024 | 46.92M |
| February 28, 2024 | 50.80M |
| February 27, 2024 | 47.27M |
| February 26, 2024 | 57.14M |
| February 23, 2024 | 48.68M |
| February 22, 2024 | 50.80M |
| February 21, 2024 | 47.27M |
| February 20, 2024 | 64.90M |
| February 16, 2024 | 56.44M |
| February 15, 2024 | 30.35M |
| February 14, 2024 | 15.37M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-42.77M
Minimum
Mar 10 2023
436.89M
Maximum
Jul 13 2020
35.93M
Average
30.70M
Median
Jul 07 2022
Enterprise Value Benchmarks
| Janux Therapeutics Inc | 2.089B |
| Retractable Technologies Inc | -13.79M |
| Mersana Therapeutics Inc | 161.86M |
| Spero Therapeutics Inc | 0.7338M |
| Vera Therapeutics Inc | 1.996B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.342M |
| Revenue (Quarterly) | 9.211M |
| Total Expenses (Quarterly) | 12.41M |
| EPS Diluted (Quarterly) | -0.06 |
| Profit Margin (Quarterly) | -25.43% |
| Earnings Yield | -22.09% |
| Normalized Earnings Yield | -22.09 |